📰 Latest Economy & Stock Market News
Gold prices dip Rs 3,600/10 gram, silver down Rs 6,000/kg as US jobs data lifts rate hike bets; buy, sell or hold?
Updated at : 2026-09-07 10:25:02

Gold and silver prices remained under pressure as stronger US jobs data raised expectations of higher interest rates. Analysts see both metals in a sideways trend, with key support and resistance levels identified for gold and silver. Investors now await US inflation data and the Federal Reserve’s September meeting for cues on the interest-rate outlook and bullion prices.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
US Stock Market: Equity funds see second straight week of outflows as investors turn cautious
Updated at : 2026-09-07 10:20:03

U.S. equity funds saw $11.12 billion in net outflows for a second straight week as rising bond yields, oil prices and Middle East tensions dampened sentiment. Strong AI-related earnings from Nvidia and Dell limited the decline. Investors favored safer assets, with money market funds attracting $48.76 billion, reflecting heightened market caution.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
Hindustan Unilever shares in focus as Capital Markets Day outlines growth levers; what are Goldman Sachs and Nomura saying?
Updated at : 2026-09-07 09:30:02

Hindustan Unilever’s Capital Markets Day outlined a strategy focused on consumption-led growth, premiumisation, market-making and new growth spaces. Goldman Sachs, Nuvama and Nomura retained Buy ratings, with target prices ranging from Rs 2,450 to Rs 2,820. HUL has raised medium-term margin guidance to 22-24%, while higher capex and underpenetrated categories are expected to support growth.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
ICICI Bank shares in focus as LIC gets RBI nod to acquire 9.99% stake in private lender
Updated at : 2026-09-07 09:25:02

ICICI Bank shares will be in focus after RBI approved LIC to acquire up to 9.99% in the lender within one year. LIC already holds over 4%. Despite recent weakness, ICICI Bank has gained 6% in 2026, with strong long-term returns. Major brokerages remain bullish on the stock.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
Nifty 30,000 target still on track; why Elara’s Harendra Kumar prefers IT, power and smallcaps
Updated at : 2026-09-07 09:20:02

We are telling people that this is the right time to look at the market constructively. Historical evidence suggests that this is the time to invest — after phases like this, FII flows also turn positive. Even now, FII flows are beginning to improve.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
Purple Style Labs shares to list today; Check GMP ahead of debut
Updated at : 2026-09-07 08:25:02

The Rs 680-crore IPO, which opened for subscription on August 31 and closed on September 2, was subscribed 1.29 times overall. Retail investors led the demand, with their portion subscribed 1.57 times, followed by qualified institutional buyers (QIBs), whose quota was subscribed 1.44 times. The non-institutional investor (NII) category was subscribed 84%.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
Three SME IPOs to list today: Ashutosh Fibre, Shanti Inorganics see GMPs above 60%
Updated at : 2026-09-07 08:20:02

Investor interest is particularly strong in the two NSE SME issues, with Ashutosh Fibre and Shanti Inorganics commanding healthy grey market premiums (GMPs) ahead of their listings.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
MCX electricity futures clock record Rs 245 crore turnover as OI touches all-time high
Updated at : 2026-09-06 17:25:01

MCX electricity futures celebrated a milestone on September 4, reaching a historic turnover of Rs 245 crore. The contract not only recorded its highest volume and open interest but also demonstrated notable growth in average daily volume this fiscal year. This surge reflects a robust market interest and expanded initiatives for managing price risks, as evidenced by consistent trading activity across all expiry months.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)
Rate this item
⭐⭐⭐⭐☆
(1 Vote)
How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alpha
Updated at : 2026-09-06 14:30:02

PGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma, and hospitals. Anandha Padmanabhan shares insights on navigating hospital capacity expansions, China-plus-one opportunities, GLP-1 dynamics, and key stock-selection strategies across healthcare sub-sectors.

Rate this item
⭐⭐⭐⭐☆
(1 Vote)

Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.